| 1 day | +1.70% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 74 | - |
Sean Christie
DFI | Director of Finance/CFO | 53 | 01/08/2021 |
Doyle Shane
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ruud Dobber
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/21/21 A | Issuer sale | Chief Operating Officer | 172,582 | 0.0781% | ||
| 7/21/21 A | Issuer sale | Director | 28,216 | 0.0128% | ||
| 7/21/21 A | Issuer sale | Chief Financial Officer | 120,253 | 0.0544% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.70% | -2.20% | - | - | 40.34B | ||
| +0.43% | +6.59% | +56.57% | +107.01% | 1,120B | ||
| +0.90% | -2.25% | +32.26% | +67.33% | 616B | ||
| +0.71% | +3.24% | +24.33% | +91.20% | 504B | ||
| -0.37% | +4.75% | +34.15% | +58.15% | 367B | ||
| +0.52% | +0.24% | +72.13% | +43.10% | 360B | ||
| -0.10% | +3.85% | +19.63% | +47.00% | 288B | ||
| -1.17% | +2.33% | -2.05% | +17.33% | 258B | ||
| -0.35% | +4.25% | +44.74% | +52.51% | 234B | ||
| -0.75% | +3.32% | +27.18% | +96.05% | 194B | ||
| Average | +0.14% | +3.31% | +34.33% | +64.41% | 437.88B | |
| Weighted average by Cap. | +0.23% | +3.52% | +39.30% | +74.38% |
Employees
3,837
Sector
Pharmaceuticals
















